Post-approval studies (Phase 4)UnknownNCT04350671What this trial is testingInterferon Beta 1a in Hospitalized COVID-19 PatientsWho this might be right forCOVID-19 Shahid Beheshti University of Medical Sciences 40
Early research (Phase 1)Ended earlyNCT04638634What this trial is testingPharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult SubjectsWho this might be right forCoronavirus Disease 2019 (COVID-19) CSL Behring 12
Not applicableStudy completedNCT04438993What this trial is testingThe COVID-19 Disease and CARdiac Events StudyWho this might be right forCOVIDCoronavirus NHS Lanarkshire 100
Testing effectiveness (Phase 2)Ended earlyNCT04475601What this trial is testingEnzalutamide Treatment in COVID-19Who this might be right forCOVID-19Corona Virus Infection Andreas Josefsson 42
Early research (Phase 1)Study completedNCT05148754What this trial is testingAn Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy VolunteersWho this might be right forCovid19HIV-1-infection Viriom 15
Testing effectiveness (Phase 2)Study completedNCT04473170What this trial is testingStudy Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19Who this might be right forCoronavirus Disease 2019 (COVID-19) Abu Dhabi Stem Cells Center 146
Not applicableStudy completedNCT04344977What this trial is testingCollection of Anti-SARS-CoV-2 Immune PlasmaWho this might be right forCoronavirus Disease 2019 (COVID-19) National Institute of Allergy and Infectious Diseases (NIAID) 151
Not applicableUnknownNCT04821570What this trial is testingTo Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer TreatmentWho this might be right forBreast CancerLung CancerMelanoma (Skin) University of Kansas Medical Center 500
Testing effectiveness (Phase 2)Study completedNCT04686773What this trial is testingOpen-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 PreventionWho this might be right forCOVID-19 R-Pharm 100
Post-approval studies (Phase 4)UnknownNCT05220280What this trial is testingSOLIDARITY Finland Plus Long-COVIDWho this might be right forCovid19Coronavirus Disease 2019SARS-CoV-2 Acute Respiratory Disease Clinical Urology and Epidemiology Working Group 400
Not applicableEnded earlyNCT05059080What this trial is testingA Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) StudyWho this might be right forCOVID-19Long COVID Hoffmann-La Roche 72
Large-scale testing (Phase 3)Looking for participantsNCT07743580What this trial is testingSecutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe DiseaseWho this might be right forSARS-CoV-2 Shionogi 2,000
Not applicableStudy completedNCT04425213What this trial is testingObesity and Mortality of Critically Ill Patients With COVID-19Who this might be right forCOVIDSevere Acute Respiratory SyndromeObesity+1 more Central Hospital, Nancy, France 250
Testing effectiveness (Phase 2)Study completedNCT04481685What this trial is testingA Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)Who this might be right forCovid19 University of Kansas Medical Center 20
Early research (Phase 1)Study completedNCT04519437What this trial is testingStudy Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19Who this might be right forHealthyChronic Stable Illness Regeneron Pharmaceuticals 974
Not applicableStudy completedNCT04452604What this trial is testingMulticentric Registry of Patients With Acute Leukemia Infected by COVID-19Who this might be right forAcute Myeloblastic LeukemiaAcute Lymphoblastic LeukemiaSARS-CoV-2 French Innovative Leukemia Organisation 79
Testing effectiveness (Phase 2)Study completedNCT04380701What this trial is testingA Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised AdultsWho this might be right forInfections, RespiratoryVirus DiseasesInfection Viral+3 more BioNTech SE 512
Early research (Phase 1)Study completedNCT05505448What this trial is testingA Trial to Learn if a COVID-19 Therapeutic is Safe and Well Tolerated, and How it Works in the Body of Healthy Adult ParticipantsWho this might be right forHealthy Regeneron Pharmaceuticals 48
Testing effectiveness (Phase 2)Ended earlyNCT04511650What this trial is testingEvaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019Who this might be right forCOVID-19Acute Respiratory Distress Syndrome (ARDS) EyePoint Pharmaceuticals, Inc. 31
Post-approval studies (Phase 4)Active Not RecruitingNCT07266558What this trial is testingEvaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)Who this might be right forSARS-CoV-2 ModernaTX, Inc. 30,000